Drugs / Pyophage
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2/3 | NCT03140085 Comparator | Jun 2017 → Dec 2018 | — | Balgrist University Hospital | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Pyophage | “intravesical Pyo bacteriophage (Pyophage; 20 mL) or intravesical placebo solution (20 mL)” PMID 32949500 ↗ Sep 2020 |
| Modality | Other / unclassified | “commercial bacteriophage cocktail” PMID 32949500 ↗ Sep 2020 |
| Route | Other | “Intravescial instillation” NCT03140085 ↗ |